Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

The multiparametric prostate resonance imaging with the prostate imaging-reporting and data system (PI-RADS): the state of art of prostate cancer diagnosis.

Favorito LA.

Int Braz J Urol. 2019 May-Jun;45(3):422-423. doi: 10.1590/S1677-5538.IBJU.2019.03.01. No abstract available.

2.

A self-tuned graph-based framework for localization and grading prostate cancer lesions: An initial evaluation based on multiparametric magnetic resonance imaging.

Chen W, Lin M, Gibson E, Bastian-Jordan M, Cool DW, Kassam Z, Liang H, Feng G, Ward AD, Chiu B.

Comput Biol Med. 2018 May 1;96:252-265. doi: 10.1016/j.compbiomed.2018.03.017. Epub 2018 Apr 3.

PMID:
29653354
3.

Does the Prostate Imaging-Reporting and Data System (PI-RADS) version 2 improve accuracy in reporting anterior lesions on multiparametric magnetic resonance imaging (mpMRI)?

Hoffmann R, Logan C, O'Callaghan M, Gormly K, Chan K, Foreman D.

Int Urol Nephrol. 2018 Jan;50(1):13-19. doi: 10.1007/s11255-017-1753-1. Epub 2017 Nov 29.

PMID:
29188489
4.

Risk of Clinically Significant Prostate Cancer Associated With Prostate Imaging Reporting and Data System Category 3 (Equivocal) Lesions Identified on Multiparametric Prostate MRI.

Sheridan AD, Nath SK, Syed JS, Aneja S, Sprenkle PC, Weinreb JC, Spektor M.

AJR Am J Roentgenol. 2018 Feb;210(2):347-357. doi: 10.2214/AJR.17.18516. Epub 2017 Nov 7.

PMID:
29112469
5.

Multiparametric MRI of the prostate: diagnostic performance and interreader agreement of two scoring systems.

Lin WC, Muglia VF, Silva GE, Chodraui Filho S, Reis RB, Westphalen AC.

Br J Radiol. 2016 Jun;89(1062):20151056. doi: 10.1259/bjr.20151056. Epub 2016 Mar 23.

6.

Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for Advanced Risk Modeling of Prostate Cancer-Patient-tailored Risk Stratification Can Reduce Unnecessary Biopsies.

Radtke JP, Wiesenfarth M, Kesch C, Freitag MT, Alt CD, Celik K, Distler F, Roth W, Wieczorek K, Stock C, Duensing S, Roethke MC, Teber D, Schlemmer HP, Hohenfellner M, Bonekamp D, Hadaschik BA.

Eur Urol. 2017 Dec;72(6):888-896. doi: 10.1016/j.eururo.2017.03.039. Epub 2017 Apr 8.

PMID:
28400169
7.

PI-RADS Version 2 Category on 3 Tesla Multiparametric Prostate Magnetic Resonance Imaging Predicts Oncologic Outcomes in Gleason 3 + 4 Prostate Cancer on Biopsy.

Faiena I, Salmasi A, Mendhiratta N, Markovic D, Ahuja P, Hsu W, Elashoff DA, Raman SS, Reiter RE.

J Urol. 2019 Jan;201(1):91-97. doi: 10.1016/j.juro.2018.08.043.

PMID:
30577397
9.

Prostate Imaging-Reporting and Data System Steering Committee: PI-RADS v2 Status Update and Future Directions.

Padhani AR, Weinreb J, Rosenkrantz AB, Villeirs G, Turkbey B, Barentsz J.

Eur Urol. 2019 Mar;75(3):385-396. doi: 10.1016/j.eururo.2018.05.035. Epub 2018 Jun 13.

10.

Multiparametric Magnetic-Resonance to Confirm Eligibility to an Active Surveillance Program for Low-Risk Prostate Cancer: Intermediate Time Results of a Third Referral High Volume Centre Active Surveillance Protocol.

Luzzago S, Musi G, Catellani M, Russo A, Di Trapani E, Mistretta FA, Bianchi R, Cozzi G, Conti A, Pricolo P, Ferro M, Matei DV, Mirone V, Petralia G, de Cobelli O.

Urol Int. 2018;101(1):56-64. doi: 10.1159/000488772. Epub 2018 May 7.

PMID:
29734177
11.

Review of Prostate Imaging Reporting and Data System version 2.

Wahab SA, Verma S.

Future Oncol. 2016 Nov;12(21):2479-2494. Epub 2016 Sep 20. Review.

PMID:
27646879
12.

Use of the Prostate Imaging Reporting and Data System (PI-RADS) for Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: A Diagnostic Meta-analysis.

Hamoen EHJ, de Rooij M, Witjes JA, Barentsz JO, Rovers MM.

Eur Urol. 2015 Jun;67(6):1112-1121. doi: 10.1016/j.eururo.2014.10.033. Epub 2014 Nov 6. Review.

PMID:
25466942
13.

Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: Prostate Imaging Reporting and Data System Version 1 versus Version 2.

Feng ZY, Wang L, Min XD, Wang SG, Wang GP, Cai J.

Chin Med J (Engl). 2016 Oct 20;129(20):2451-2459. doi: 10.4103/0366-6999.191771.

14.

Magnetic resonance imaging of the prostate: interpretation using the PI-RADS V2.

Torregrosa Andrés A, Otero García M, Sineiro Galiñanes M.

Radiologia. 2017 Mar - Apr;59(2):128-138. doi: 10.1016/j.rx.2016.10.005. Epub 2016 Dec 21. English, Spanish.

15.

Opportunities for multiparametric MRI with PI-RADS v2 to make a difference.

Tempany C.

Future Oncol. 2016 Nov;12(21):2397-2399. Epub 2016 Sep 19. No abstract available.

PMID:
27641695
16.

Is it Time to Perform Only Magnetic Resonance Imaging Targeted Cores? Our Experience with 1,032 Men Who Underwent Prostate Biopsy.

Pepe P, Garufi A, Priolo GD, Galia A, Fraggetta F, Pennisi M.

J Urol. 2018 Oct;200(4):774-778. doi: 10.1016/j.juro.2018.04.061. Epub 2018 Apr 19.

PMID:
29679618
17.

Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: a prospective study.

Thompson JE, Moses D, Shnier R, Brenner P, Delprado W, Ponsky L, Pulbrook M, Böhm M, Haynes AM, Hayen A, Stricker PD.

J Urol. 2014 Jul;192(1):67-74. doi: 10.1016/j.juro.2014.01.014. Epub 2014 Feb 8.

PMID:
24518762
18.

The efficiency of multiparametric magnetic resonance imaging (mpMRI) using PI-RADS Version 2 in the diagnosis of clinically significant prostate cancer.

Zhao C, Gao G, Fang D, Li F, Yang X, Wang H, He Q, Wang X.

Clin Imaging. 2016 Sep-Oct;40(5):885-8. doi: 10.1016/j.clinimag.2016.04.010. Epub 2016 Apr 26.

PMID:
27179959
19.

Prostate Cancer: The European Society of Urogenital Radiology Prostate Imaging Reporting and Data System Criteria for Predicting Extraprostatic Extension by Using 3-T Multiparametric MR Imaging.

Kayat Bittencourt L, Litjens G, Hulsbergen-van de Kaa CA, Turkbey B, Gasparetto EL, Barentsz JO.

Radiology. 2015 Aug;276(2):479-89. doi: 10.1148/radiol.15141412. Epub 2015 Apr 3.

PMID:
25848900
20.

[Preliminary applicability evaluation of Prostate Imaging Reporting and Data System version 2 diagnostic score in 3.0T multi-parameters magnetic resonance imaging combined with prostate specific antigen density for prostate cancer].

Zuo MZ, Zhao WL, Wei CG, Zhang CY, Wen R, Gu YF, Li MJ, Zhang YY, Wu JF, Li X, Shen JK.

Zhonghua Yi Xue Za Zhi. 2017 Dec 19;97(47):3693-3698. doi: 10.3760/cma.j.issn.0376-2491.2017.47.003. Chinese.

PMID:
29325321

Supplemental Content

Support Center